Antibodies against human CSF-1R and uses thereof

US9499626B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Nikolaos Dimoudis · Wielenbach, DE
• Georg Fertig · Penzberg, DE
• Alexander Fidler · Penzberg, DE
• Klaus Kaluza · Bad Heilbrunn, DE
• Marlene Thomas · Penzberg, DE
• Carola Ries · Penzberg, DE
• Stefan Seeber · Penzberg, DE
• Martin Lanzendoerfer · Tutzing, DE

Key dates

• Filing date: Mar 6, 2015
• Grant date: Nov 22, 2016
• Expiry date: Mar 6, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.